Pacira is committed to reversing this trend for our patients, practitioners, and communities
Overreliance on opioids in the postsurgical setting has caused a rapid deluge of opioid misuse, abuse, and addiction, leading to our nation’s overall societal epidemic.
91 Americans die every day from opioid overdose and nearly half of those deaths involved a prescription opioid1
Four in five new heroin users started out misusing prescription painkillers2
3 million patients went on to persistent opioid use after surgery in 2016 alone3
Following surgery, patients receive ~85 opioid pills, whether they need them or not3
“Decreasing the amount of pills out in the world is a good thing. When you prescribe 60 and they only take three, the extras are sitting in the medicine cabinet and that’s where the trouble happens. There are too many opioids floating around in the community, and we should be doing all we can to decrease those numbers.”
-Peggy Compton, PhD, RN
This Is an epidemic that knows no gender, race, or socioeconomic boundaries. It is our college students having their wisdom teeth out and being handed a bottle of pills with no education about their dangers; it’s our mothers who are overprescribed opioids after a C-section; it’s our parents having joint replacements and receiving a prescription for far too many pills with far too many refills.
It can happen to anyone, and that’s why we at Pacira believe that everyone should be offered a non-opioid option for postsurgical pain control.
Tackling our nation’s complex opioid epidemic will require a multifactorial strategy built on the innovative approach of forward-thinking biotech companies like Pacira that challenge and transform the way we think about—and treat—postsurgical pain in the United States.
Educating doctors and patients about the importance of non-opioid pain management is central to the Pacira mission to improve patient care.
In 2016, we were proud to launch Choices Matter, our national education campaign aimed at empowering patients to proactively discuss postsurgical pain management, including non-opioid options, with their doctors. We’re building a coalition of likeminded individuals and organizations to generate widespread public awareness of the role that postsurgical opioids play in the larger public health crisis in the United States, while highlighting the opportunity to alleviate the risks associated with opioid dependence and/or addiction through the utilization of non-opioid pain management approaches.
Our mission to provide a non-opioid option for postsurgical pain to all patients spans across the globe
Pacira has donated over 2700 vials of EXPAREL® (bupivacaine liposome injectable suspension) to locations across the world that otherwise have no alternatives for postsurgical pain management other than opioids. These donations have assisted patients undergoing a range of surgical procedures including hip and knee replacement, wisdom tooth extraction, and hernia repair.